This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Council of Scientific and Industrial Research. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Vinod Scaria: Innovator in HIV Research
Introduction
Vinod Scaria is a prominent inventor based in Delhi, India. He has made significant contributions to the field of biomedical research, particularly in the area of HIV. His innovative work focuses on the identification of human microRNA targets within the HIV genome, which has potential therapeutic implications.
Latest Patents
Vinod Scaria holds a patent titled "Human microRNA targets in HIV genome and a method of identification thereof." This invention relates to the discovery of six human microRNAs that target specific genes in the HIV genome, including vpr, env, and vif. The identified microRNAs are hsa-miR-29a, hsa-miR-29b, hsa-miR-29c, hsa-mir-149, hsa-mir-324-5p, and hsa-mir-378. These microRNAs or their homologues can be utilized as therapeutics against HIV infection. The invention also presents a novel strategy to target HIV-1 genes using human microRNAs to inactivate or block HIV activity. The computational approach for identifying these targets has been validated through experimental methods.
Career Highlights
Vinod Scaria is associated with the Council of Scientific and Industrial Research, where he has been involved in groundbreaking research. His work has garnered attention for its potential to advance the understanding and treatment of HIV.
Collaborations
Vinod has collaborated with notable colleagues, including Samir Kumar Brahmachari and Manoj Hariharan, contributing to the collective effort in HIV research.
Conclusion
Vinod Scaria's innovative research and patent in the field of HIV highlight his role as a key inventor in biomedical science. His work not only advances scientific knowledge but also opens new avenues for therapeutic interventions against HIV.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
